Apollomics vs TME Pharma
Apollomics
We are a biopharmaceutical company committed to the discovery and development of mono- and combination cancer therapies
26 employees · est. 2015 · Foster City, United States
TME Pharma
Developing novel therapies for treatment of the most aggressive cancers by acting on the tumor microenvironment (TME)
12 employees · est. 1998 · Berlin, Germany
TME Pharma is the older company (2015 vs 1998).
Side-by-Side Comparison
| Metric | Apollomics | TME Pharma |
|---|---|---|
| Founded | ||
| Founded | 2015 | 1998 older |
| Headquarters | ||
| Headquarters | Foster City, United States | Berlin, Germany |
| Employees | ||
| Employees | 26 | 12 |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post-IPO Equity | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $262.60M | $138.73M |
| Funding Rounds | ||
| Funding Rounds | 5 | 13 |
| Services | ||
| Services | Not tracked yet | development of novel cancer therapies, conducting and managing clinical trials, scientific research and development, collaborative therapeutic solutions |
| Target Customers | ||
| Target Customers | Not tracked yet | oncologists, medical researchers, pharmaceutical companies, healthcare providers, cancer patients |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical CompanyOncology TherapiesCombination TherapiesCancer TreatmentDrug DevelopmentImmune System +8 | Tumor MicroenvironmentCancer TherapiesGlioblastomaNOX-A12Spiegelmer PlatformImmune System Modulation +9 |
| Website | ||
| Website | apollomicsinc.com | tmepharma.com |
About Apollomics
Apollomics is a biopharmaceutical company with a clear mission to discover and develop mono- and combination cancer therapies. Established in 2016, Apollomics has made strategic moves to operate in both the U.S. and China, aiming to harness synergies by collaborating with biotechnology companies in...
About TME Pharma
TME Pharma is a clinical-stage biotechnology company headquartered in Germany, specializing in developing novel therapies targeting the tumor microenvironment (TME) which is crucial in treating aggressive forms of cancer. With a mission to enhance treatment outcomes, the company’s platform aims at b...
Also comparing in this category
Comparing more than these two?
Get Apollomics, TME Pharma and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Apollomics compare?
A PDF of Apollomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Apollomics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Apollomics on 12 Sep 2024, and TME Pharma on 14 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
